Alpha Cancer Technologies Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$3M
- Investors
-
4
Alpha Cancer Technologies General Information
Description
Developer of clinical-stage biologic drugs designed to treat immuno-oncology and autoimmune diseases. The company's proprietary drugs use recombinant human alpha-fetoprotein (AFP) to treat autoimmune disease indications and its targeted delivery platform together with chemotherapy is used to treat cancer, enabling healthcare practitioners to enhance the performance of chemotherapy at a lower dose without any damage to healthy cells.
Contact Information
Website
www.alpha-cancer.comCorporate Office
- MaRs Centre - South Tower
- 200-101 College Street
- Toronto, Ontario M5G 1L7
- Canada
Corporate Office
- MaRs Centre - South Tower
- 200-101 College Street
- Toronto, Ontario M5G 1L7
- Canada
Alpha Cancer Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC | 08-Mar-2019 | $3M | Completed | Clinical Trials - Phase 2 | ||
| 8. Later Stage VC | 01-Jan-2019 | Completed | Clinical Trials - Phase 2 | |||
| 7. Later Stage VC | Completed | Clinical Trials - Phase 2 | ||||
| 6. Later Stage VC | 17-Aug-2018 | Completed | Clinical Trials - Phase 2 | |||
| 5. Later Stage VC | 01-Dec-2017 | Completed | Clinical Trials - Phase 1 | |||
| 4. Later Stage VC | 15-Oct-2015 | Completed | Clinical Trials - Phase 1 | |||
| 3. Reverse Merger | 18-Nov-2014 | Cancelled | Pre-Clinical Trials | |||
| 2. Grant | 28-Feb-2013 | $3M | $2.1M | Completed | Pre-Clinical Trials | |
| 1. Angel (individual) | 01-Jan-2013 | $2.1M | $2.1M | Completed | Pre-Clinical Trials |
Alpha Cancer Technologies Comparisons
Industry
Financing
Details
Alpha Cancer Technologies Competitors (17)
One of Alpha Cancer Technologies’s 17 competitors is Genentech, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Affibody | Venture Capital-Backed | Solna, Sweden | ||||
| Nexoplex bio | Formerly VC-backed | Emeryville, CA | ||||
| Fusion Pharmaceuticals | Formerly VC-backed | Hamilton, Canada | ||||
| Replimune | Formerly VC-backed | Woburn, MA |
Alpha Cancer Technologies Patents
Alpha Cancer Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022313115-A1 | Alpha-fetoprotein bioconjugates for disease treatment | Inactive | 23-Jul-2021 | ||
| CA-3226570-A1 | Alpha-fetoprotein bioconjugates for disease treatment | Pending | 23-Jul-2021 | ||
| EP-4373844-A1 | Alpha-fetoprotein bioconjugates for disease treatment | Pending | 23-Jul-2021 | ||
| EP-4373844-A4 | Alpha-fetoprotein bioconjugates for disease treatment | Pending | 23-Jul-2021 | ||
| US-20250121075-A1 | Alpha-fetoprotein bioconjugates for disease treatment | Pending | 23-Jul-2021 | A61K47/64 |
Alpha Cancer Technologies Signals
Alpha Cancer Technologies Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bristol-Myers Squibb | Corporation | Minority | ||
| Innovation Grade Ventures | Venture Capital | Minority | ||
| Federal Economic Development Agency for Southern Ontario | Government | |||
| Angel (individual) | Minority |
Alpha Cancer Technologies FAQs
-
When was Alpha Cancer Technologies founded?
Alpha Cancer Technologies was founded in 2008.
-
Where is Alpha Cancer Technologies headquartered?
Alpha Cancer Technologies is headquartered in Toronto, Canada.
-
What is the size of Alpha Cancer Technologies?
Alpha Cancer Technologies has 8 total employees.
-
What industry is Alpha Cancer Technologies in?
Alpha Cancer Technologies’s primary industry is Drug Discovery.
-
Is Alpha Cancer Technologies a private or public company?
Alpha Cancer Technologies is a Private company.
-
What is the current valuation of Alpha Cancer Technologies?
The current valuation of Alpha Cancer Technologies is .
-
What is Alpha Cancer Technologies’s current revenue?
The current revenue for Alpha Cancer Technologies is .
-
How much funding has Alpha Cancer Technologies raised over time?
Alpha Cancer Technologies has raised $36.5M.
-
Who are Alpha Cancer Technologies’s investors?
Bristol-Myers Squibb, Innovation Grade Ventures, Federal Economic Development Agency for Southern Ontario, and have invested in Alpha Cancer Technologies.
-
Who are Alpha Cancer Technologies’s competitors?
Genentech, Affibody, Nexoplex bio, Fusion Pharmaceuticals, and Replimune are some of the 17 competitors of Alpha Cancer Technologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process